Logistics providers are executing rapid capacity expansions to accommodate specialized temperature-controlled storage required for GLP-1 class therapeutics. The rapid adoption of these metabolic treatments has created unprecedented demand for continuous cold-chain tracking from production facilities to retail points of distribution.
Capacity Constraints
Freight forwarders report localized shortages of specialized refrigerated transport units along primary export corridors. In response, pharmaceutical distributors are signing long-term take-or-pay contracts with logistics operators to guarantee refrigerated air freight capacity through 2026.